Siemens Medical Systems has named John Pavlidis, formerly vice president of the company’s U.S. MRI division, to the post of president of the company’s ultrasound division in Issaquah, WA. Pavlidis joined Siemens in 1990 as MRI product
Siemens Medical Systems has named John Pavlidis, formerly vice president of the companys U.S. MRI division, to the post of president of the companys ultrasound division in Issaquah, WA. Pavlidis joined Siemens in 1990 as MRI product specialist, and has served in its MRI unit in both Iselin, NJ, and Erlangen, Germany. He replaces Wolfgang Reim, who has left the company. The firm also named two other ultrasound executives to new posts: David Quist is now vice president of marketing and sales support, and John Benson is vice president of product creation.
Siemens has also appointed Joe Camaratta to the post of vice president for marketing, sales, and service. He replaces Alex Stein, who has left the position for another within Siemens. Camarattas duties will include strategic planning, program development, and marketing communications for Siemens Iselin-based divisions. He joined Siemens in 1984, and has previously served as vice president for international marketing in Siemens Medical Engineering Groups MRI division in Erlangen, and as manager for the companys MRI division.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.